Autoimmune pancreatitis classification: Difference between revisions

	Autoimmune pancreatitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune pancreatitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Guidelines for Management
Case Studies
Case #1
Autoimmune pancreatitis classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Autoimmune pancreatitis classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Autoimmune pancreatitis classification
CDC on Autoimmune pancreatitis classification
Autoimmune pancreatitis classification in the news
Blogs on Autoimmune pancreatitis classification
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Autoimmune pancreatitis classification

Revision as of 18:47, 18 December 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Autoimmune pancreatitis can be
- Primary (when main pathology is in pancreas) or
- Secondary (when associated with other systemic autoimmune diseases such as IgG4-associated cholangitis, chronic sclerosing sialadenitis, tubulointerstitial nephritis, and ulcerative colitis
Autoimmune pancreatitis may be classified into two types.
- Type 1 AIP
- Type 2 AIP or idiopathic duct-centric pancreatitis

Type 1 AIP meets the HISORt criteria.^[1]^[2]
Type 1 AIP involves pancreas as one part of a systemic IgG4-positive disease.
Type 1 patients have high relapse rates when compared to type 2 patients.^[3]
Type 1 patients are usually older on presentation.
Type 1 patients have higher prevalence of increased IgG4 levels.
Type 1 patients have greater extrapancreatic organ involvement compared to Type 2 AIP patients.

Criteria
(H)	Histology suggestive of autoimmine pancreatitis
(I)	Pancreatic imaging suggestive of autoimmine pancreatitis
(S)	Serology (IgG4 ≥2 times the upper limit of normal)
(O)	Other organ involvement Biliary strictures Parotid/lacrimal gland involvement Mediastinal lymphadenopathy Retroperitoneal fibrosis
(Rt)	Response to steroid treatment

↑ Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, Petersen BT, Topazian MA, Vege SS (2009). "A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer". Clin. Gastroenterol. Hepatol. 7 (10): 1097–103. doi:10.1016/j.cgh.2009.04.020. PMID 19410017.
↑ Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, Clain JE, Pearson RK, Petersen BT, Vege SS, Farnell MB (2006). "Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience". Clin. Gastroenterol. Hepatol. 4 (8): 1010–6, quiz 934. doi:10.1016/j.cgh.2006.05.017. PMID 16843735.
↑ Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, Pearson RK, Smyrk TC, Petersen BT, Topazian MD, Takahashi N, Farnell MB, Vege SS (2010). "Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis". Gastroenterology. 139 (1): 140–8, quiz e12–3. doi:10.1053/j.gastro.2010.03.054. PMID 20353791.

@@ Line 4: / Line 4: @@
 {{CMG}}; {{AE}}
 ==Overview==
-There is no established system for the classification of [disease name].
-OR
-[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
-OR
-[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
-[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
-OR
-Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
-OR
-If the staging system involves specific and characteristic findings and features:
-According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-The staging of [malignancy name] is based on the [staging system].
-OR
-There is no established system for the staging of [malignancy name].
 ==Classification==